chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Hypoaesthesia, Neuralgia
Clinical narrative: Pain in L shoulder; Weakness; Nerve pain; Numbness; This is a spontaneous report from a non-contactable consumer, the patient. A 24-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 30Apr2021 at 15:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 01Apr2021 at 15:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. On an unknown date in May2021, the patient experienced pain in L shoulder, weakness, nerve pain, numbness. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of events. The clinical outcome of the events pain in L shoulder, weakness, nerve pain, numbness was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Heavy menstrual bleeding, Menstruation irregular, Vaginal haemorrhage
Clinical narrative: Four hours after receiving vaccine, patient began to feel faint; Went to the bathroom and had onset of extremely heavy vaginal bleeding; Not consistent with the timing of cycle, 1 1/2 week early menstrual cycle, lasting 9 days and usually it only last 4-5 days; Menstrual cycle lasting 9 days and usually it only last 4-5 days; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 02Aug2021 at 10:30(at the age of 24-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified probiotic capsules from wholefoods for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 02Aug2021 at 14:30, 4 hours after receiving vaccine, the patient began to feel faint, went to the bathroom and had onset of extremely heavy vaginal bleeding and was not consistent with the timing of cycle. 1 1/2 week early menstrual cycle which lasted 9 days and usually it only last 4-5 days. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events  began to feel faint, went to the bathroom and had onset of extremely heavy vaginal bleeding and was not consistent with the timing of cycle, 1 1/2 week early menstrual cycle which lasted 9 days and usually it only last 4-5 days was resolved on an unknown date in Aug2021.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Menstruation irregular
Clinical narrative: Menstrual cycle was early by two weeks; Menstrual cycle was heavier than normal.; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0186) via an unspecified route of administration in the left arm on 12Jul2021 at 17:30 (at the age of 49-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on 02Aug2021 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 19Jul2021, the patient reported that her menstrual cycle was early by two weeks and was heavier than normal. The patient was on that new schedule at the time of reporting even after the second dose on 02Aug2021. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of reported events. The clinical outcome of the events menstrual cycle was early by two weeks and was heavier than normal was unknown at the time of this report.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Antibody test, Heavy menstrual bleeding, SARS-CoV-2 test
Clinical narrative: Next monthly menstrual cycle was extremely heavy with clots and has continued since that second vaccine So, March 2021 to this date the cycle have been horrible.; This is a spontaneous report from a contactable other healthcare professional. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN06205) via an unspecified route of administration in the arm left on  05Mar2021 at 16:00 (at the age of 46-year-old) and the patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on an unknown date in 2021, as a single dose for COVID-19 immunisation. Medical history included kidney transplant. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included immunosuppressants (MANUFACTURER UNKNOWN), from an unknown date for kidney transplant and unknown if ongoing. On an unknown date in Mar2021, the patient experienced next monthly menstrual cycle was extremely heavy with clots and had continued since that second vaccine So, March 2021 to this date the cycle had been horrible. On an unknown date, the patient underwent SARS CoV-2 test (blood test) and the result was unknown. On an unknown date, the patient underwent antibody test and the result was no/undetectable antibodies. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the event, menstrual cycle was extremely heavy with clots and had continued since that second vaccine was unknown at the time of the report.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Ear pain
Clinical narrative: Painful earache; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 09Aug2021 at 11:30 (at the age of 64-year-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. On 09Aug2021 at 19:00, the patient experienced painful earache. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event painful earache was not resolved at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: This is a spontaneous report from a non-contactable nurse, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Aug2021 at 15:30 (at the age of 40-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included unspecified beta blocker medications for unspecified indication from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. On 11Aug2021 at 01:00, the patient experienced severe joint pain in injection arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of severe joint pain in injection arm and included treatment with unspecified anti-inflammatory medicine from an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe joint pain in injection arm was not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Chills, Dizziness, Headache, Insomnia
Clinical narrative: Severe breast pain; Fever; Chills; Headache; Insomnia; Nausea; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the left arm on 07Aug2021 at 10:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included fish oil (MANUFACTURER UNKNOWN), vitamin d nos (MANUFACTURER UNKNOWN) and PRENATAL; all from unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Aug2021 at 21:30, the patient experienced severe breast pain, fever, chills, headache, insomnia, nausea and dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of events severe breast pain, fever, chills, headache, insomnia, nausea and dizziness were resolved on an unknown date in Aug2021.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: Severe breast pain; Fever; Chills; Headache; Insomnia; Nausea; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the left arm on 07Aug2021 at 10:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included fish oil (MANUFACTURER UNKNOWN), vitamin d nos (MANUFACTURER UNKNOWN) and PRENATAL; all from unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Aug2021 at 21:30, the patient experienced severe breast pain, fever, chills, headache, insomnia, nausea and dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of events severe breast pain, fever, chills, headache, insomnia, nausea and dizziness were resolved on an unknown date in Aug2021.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Swollen and extremely painful lymphnodes; Swollen and extremely painful lymphnodes; This is a spontaneous report from a contactable other healthcare professional. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3181) via an unspecified route of administration in the right arm on 10Aug2021 at 14:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included graves' disease. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included levothyroxine (MANUFACTURER UNKNOWN) from unknown date for unknown indication and unknown if ongoing. On 11Aug2021 at 17:30, the patient experienced swollen and extremely painful lymph nodes. The events resulted in emergency room/department visit or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen and extremely painful lymph nodes was not resolved at the time of this report.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Headache
Clinical narrative: Burning bi-laterally; Severe headache; This is a spontaneous report from a contactable pharmacist. A 61-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via intramuscular route of administration in the left arm on 05Aug2021 at 11:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ibuprofen (MOTRIN) over the counter (OTC), taken for an unknown indication from an unknown date and unknown if ongoing. On 05Aug2021 at 12:00, the patient experienced burning bi-laterally and severe headache. The events did not result in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events burning bi-laterally and severe headache was not resolved at the time of this report.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Joint range of motion decreased, Joint stiffness, Mobility decreased, Pain in extremity
Clinical narrative: Since the time of vaccination have experience increasing psin in both the left and right upper arms, across my shoulders which has affected my range of motion.  Extreme pain in the mornings; increasing pain in both the left and right upper arms, across my shoulders; increasing pain in both the left and right upper arms, across my shoulders which has affected my range of motion; Extreme pain in the mornings with very limited mobility in upper body.; joint stiffness and tightness; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0186) via an unspecified route of administration in the left arm on 07Jun2021 at 13:45 (at the age of 64-year-old), as a single dose for COVID-19 immunisation. The patient had no medical history and had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included colecalciferol (D-3) and calcium (MANUFACTURER UNKNOWN) and unspecified multivitamin; all for unspecified indication from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO183) via an unspecified route of administration in the left arm on 17May2021at 13:00 (at the age of 64-year-old), as a single dose for COVID-19 immunisation.  On 07Jun2021 at 14:00, since the time of vaccination, the patient experienced increasing pain in both the left and right upper arms, across shoulders which had affected range of motion, extreme pain in the mornings with very limited mobility in upper body. Tried to treat with heat therapy and Tylenol but little relief. In pain daily to varying degrees, patient also experienced joint stiffness and tightness. Therapeutic measures were taken as a result of the events and included treatment with heat therapy and Tylenol. Since the vaccination, the patient had been tested for COVID-19. On 13Jul2021, the patient underwent lab tests and procedures which included COVID-19 virus test and the result was negative. The clinical outcome of the event increasing pain in both the left and right upper arms, across shoulders which had affected range of motion, extreme pain in the mornings with very limited mobility in upper body and joint stiffness and tightness was not resolved at the time of this report.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Rash papular, Rash pruritic
Clinical narrative: Approximately 5-6 days after the 2nd vaccine dose I have broken out in an itchy skin rash; The breakouts are located in random places (e.g., small clumps on shoulders, individual lumps on stomach, back, hips, inner thighs, arms), but not at the vaccination site.; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Aug2021 at 11:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy and stupidity. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included thyroid (ARMOUR THYROID), herbs and calcium (MANUFACTURER UNKNOWN) all from unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Aug2021, approximately 5-6 days after the second vaccine dose, the patient had broken out in an itchy skin rash that she thought may be due to fleas, mosquitos, or bedbugs, however, there was no evidence of any in her home. The breakouts were located in random places (e.g., small clumps on shoulders, individual bumps on stomach, back, hips, inner thighs, arms), but not at the vaccination site. Rash was still active, not recovered at the time of this report. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events the patient had broken out in an itchy skin rash that she thought may be due to fleas, mosquitos, or bedbugs, however, there was no evidence of any in her home; the breakouts were located in random places (e.g., small clumps on shoulders, individual bumps on stomach, back, hips, inner thighs, arms), but not at the vaccination site was not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Cold sweat, Fatigue, Headache, Insomnia
Clinical narrative: Chest pain upper left quadrant; Ringing in ears; Muscle weakness; Cold sweats; Insomnia; Headache; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old male patient received the second dose of BNT162b2 (COMIRNATY; Lot Number: FA7485) via an unspecified route of administration in the left arm on 13Aug2021 at 14:15 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. The patient previously took BNT162b2 (COMIRNATY; Lot Number: EW0612) via an unspecified route of administration in the left arm on 21Jul2021 at 14:15 as a single dose for COVID-19 immunisation. On 13Aug2021 at 16:45, the patient experienced chest pain upper left quadrant, ringing in ears, muscle weakness, cold sweats, insomnia, headache and fatigue. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chest pain upper left quadrant, ringing in ears, muscle weakness, cold sweats, insomnia, headache and fatigue was not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Muscular weakness, Tinnitus
Clinical narrative: Chest pain upper left quadrant; Ringing in ears; Muscle weakness; Cold sweats; Insomnia; Headache; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old male patient received the second dose of BNT162b2 (COMIRNATY; Lot Number: FA7485) via an unspecified route of administration in the left arm on 13Aug2021 at 14:15 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. The patient previously took BNT162b2 (COMIRNATY; Lot Number: EW0612) via an unspecified route of administration in the left arm on 21Jul2021 at 14:15 as a single dose for COVID-19 immunisation. On 13Aug2021 at 16:45, the patient experienced chest pain upper left quadrant, ringing in ears, muscle weakness, cold sweats, insomnia, headache and fatigue. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chest pain upper left quadrant, ringing in ears, muscle weakness, cold sweats, insomnia, headache and fatigue was not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Nasal congestion, Parosmia, Vaccination site urticaria
Clinical narrative: On day 2 there is a smell of metal in nose / stuffy; On day 2 there is a smell of metal in nose / stuffy; In day 2 there is a couple inch welp forming close to injection site in right shoulder; This is a spontaneous report from a contactable other healthcare professional, the patient. A 48-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 11Aug2021 at 14:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 13Aug2021 at 13:15, on day 2 there was a smell of metal in nose/stuffy and there was a couple inch welp forming close to injection site in right shoulder. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events on day 2 there was a smell of metal in nose/stuffy and in day 2 there was a couple inch welp forming close to injection site in right shoulder was unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Decreased appetite, Headache, Neck pain
Clinical narrative: Fever; Chills; Body aches; Headache; Neck pain; Weakness; Loss of appetite; This is a spontaneous report from a non-contactable nurse, the patient. A 38-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Aug2021 at 17:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 and known allergies to penicillin. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any concomitant medication. The patient did not receive other vaccines within four weeks prior to the COVID vaccine. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 21Jul2021 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. On 11Aug2021, the patient underwent COVID-19 test and the result was negative. On 13Aug2021 at 06:00, the patient experienced fever, chills, body aches, headache, neck pain, weakness and loss of appetite. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events fever, chills, body aches, headache, neck pain, weakness and loss of appetite was not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, SARS-CoV-2 test
Clinical narrative: Fever; Chills; Body aches; Headache; Neck pain; Weakness; Loss of appetite; This is a spontaneous report from a non-contactable nurse, the patient. A 38-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Aug2021 at 17:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 and known allergies to penicillin. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any concomitant medication. The patient did not receive other vaccines within four weeks prior to the COVID vaccine. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 21Jul2021 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. On 11Aug2021, the patient underwent COVID-19 test and the result was negative. On 13Aug2021 at 06:00, the patient experienced fever, chills, body aches, headache, neck pain, weakness and loss of appetite. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events fever, chills, body aches, headache, neck pain, weakness and loss of appetite was not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hypersomnia, Pain in jaw
Clinical narrative: The third day the jaw pain; Slept all day the second day; Tiredness the day of the shots; This is a spontaneous report from a non-contactable consumer, the patient. A 16-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the left arm on 02Aug2021 at 11:00 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received amoxicillin (MANUFACTURER UNKNOWN), for unknown indication from an unknown date and experienced drug allergy. On 02Aug2021, the patient experienced tiredness the day of the shots, slept all day the second day (on 03Aug2021) and the third day (04Aug2021 at 04:00) the jaw pain started up to the moment 15Aug2021. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tiredness the day of the shots, slept all day was unknown while that of the jaw pain started up was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Dry throat, Nasal disorder
Clinical narrative: Open nasal passage, more than usual; Drying out the back of "my" throat; This is a spontaneous report from a non-contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the left arm on 11Aug2021 at 17:00 (at the age of 53-year-old), as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. On 12Aug2021 at 16:00, the patient experienced open nasal passage, more than usual and that was drying out the back of throat. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events open nasal passage, more than usual and that was drying out the back of throat was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, SARS-CoV-2 test
Clinical narrative: Persisting sore throat for 3 days; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 12Aug2021 at 14:45 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13Aug2021 at 05:30, the patient experienced persisting sore throat for 3 days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had been tested for COVID-19. On 13Aug2021, the patient underwent rapid test (nasal swab) and the result was negative. Since the vaccination, the patient has been tested for COVID-19. The clinical outcome of the event persisting sore throat for 3 days was not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 14Aug2021 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient also received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on an unknown date inJul2021 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. On 14Aug2021, the patient experienced sore arm. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore arm was unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Hyperhidrosis, Nasopharyngitis, Pyrexia
Clinical narrative: Fever, cold/chills and sweats.  Had to take 1 day off of work for the 1st shot and 3 days off the 2nd round.  Felt 10x worse than when I had Covid back in November.; Cold; Chills; Sweats; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in Apr2021 at 16:00 (at the age of 44-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on an unknown date in Apr2021 (at the age of 44-year-old); both as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. On an unknown date in Apr2021 at 16:00, the patient experienced fever, cold, chills and sweats, had to take 1 day off of work for the 1st shot and 3 days off the 2nd round, felt 10 times worse than when, had COVID back in November. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events, fever, cold, chills and sweats was resolved with sequelae on an unknown date in 2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Hands and forearms went numb. Numbness worsening closer to my hands and very numb from wrists to finger tips; This is a spontaneous report from a non-contactable nurse, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FD8448) via an unspecified route of administration in the left arm on 09Aug2021 at 17:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to pollen, cats and dust. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Aug2021 at 10:00, the patient's hands and forearms went numb, numbness was worsening closer to hands and very numb from wrists to finger tips. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event hands and forearms went numb, numbness was worsening closer to hands and very numb from wrists to finger tips was unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Vaccination site joint pain
Clinical narrative: Randomly I have sharp pains in my shoulders where I received the vaccine. I got the shot in one arm and then 2 weeks later the other arm. It's not unbearable pain but it comes and goes and it's pretty; first dose on 10Apr2021, second dose on 24Apr2021; This is a spontaneous report from a non-contactable consumer, the patient. A 40-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 24Apr2021 at 12:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included overweight, blood pressure high and known allergy to mild shellfish allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included valsartan (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 12:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. On 25Apr2021, the patient experienced sharp pains in his shoulders where he received the vaccine, got the shot in one arm and then 2 weeks later the other arm. It was not unbearable pain but it came and went and it was pretty consistently happening to me, the patient was not thinking about it and was busy with things and then the pain happened a couple times then went away. it mostly went away for a couple months and now was back more often. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sharp pains in his shoulders where he received the vaccine was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Gait disturbance, SARS-CoV-2 test
Clinical narrative: Severe shoulder and hip pain; walking with a limp; This is a spontaneous report from a non-contactable nurse, the patient. A 38-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration in the left arm on 05Aug2021 at 17:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received sulfur (MANUFACTURER UNKNOWN) for an unknown indication on unknown date and experienced drug allergy. On 13Aug2021 at 12:00, the patient experienced severe shoulder and hip pain and currently walking with a limp. On 12Aug2021, the patient underwent COVID-19 virus test via nasal swab and the result was negative. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events severe shoulder and hip pain and currently walking with a limp was not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Blister, Rash
Clinical narrative: Rash flat; Vesicles spread across body; This is a spontaneous report from a non-contactable healthcare professional. A 38-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7484) via an unspecified route of administration on an unknown date in Aug2021 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications were not reported. On an unknown date in Aug2021, the patient experienced rash flat and with vesicles spread across body within 48 hours. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the rash flat and vesicles which included treatment with unspecified anti-histamines and unspecified topical pain ointments. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events rash flat and vesicles were unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site hypoaesthesia, Vaccination site pain
Clinical narrative: Mild but persistent numbness/pain around injection site of 2nd dose (left arm); Mild but persistent numbness/pain around injection site of 2nd dose (left arm); This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 21Apr2021 at 11:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the right arm on 31Mar2021 at 11:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 11:30, the patient experienced mild but persistent numbness/pain around injection site of 2nd dose (left arm). Not debilitating or overly impactful but always present. Concerning for future arm mobility/use in older age. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events mild but persistent numbness/pain around injection site of 2nd dose (left arm) was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic, Urticaria
Clinical narrative: Itchy rash at time of injection; Small patches of hives all over my body that come and go. Usually on ''my'' neck, face, thighs, and wrist.; This is a spontaneous report from a non-contactable consumer, the patient. A 23-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 12Aug2021 at 15:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 12Aug2021 at 17:00, the patient experienced Itchy rash at time of injection and had since gotten small patches of hives all over her body that come and go usually on her neck, face, thighs, and wrist. Usually, the patches occurred 1-3 times a day but changed locations. Nothing else had changed in her daily routine or products that would cause hives. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcome of the event Itchy rash at time of injection, small patches of hives all over her body that come and go usually on her neck, face, thighs, and wrist was not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.